Neovasc Profit Margin 2012-2019 | NVCN
Current and historical gross margin, operating margin and net profit margin for Neovasc (NVCN) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Neovasc net profit margin as of September 30, 2019 is -544.24%.
|Neovasc Annual Profit Margins
|Neovasc Quarterly Profit Margins
||Medical Instruments Manufacturing
Neovasc Inc. is a specialty medical device company. It develops, manufactures and markets products for the cardiovascular marketplace. The Company's products include the Tiara (TM) mitral valve prosthesis in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer (TM) for the treatment of refractory angina and a line of advanced biological tissue products that are used as key components in third-party medical products, including transcatheter heart valves. Neovasc Inc. is headquartered in Richmond, Canada.